Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Saxagliptin intermediate via CN105037245A. High purity, scalable process for DPP-4 inhibitor manufacturing supply chain optimization and cost efficiency.
Patent CN1219758C reveals a scalable inclusion resolution method for di-tert-butyl thiosulfinate, offering dual-configuration access and significant cost reduction potential.
Discover the efficient 5-step synthesis of (-)-newbouldine via FeCl3 catalysis. A reliable supplier solution for high-purity pharmaceutical intermediates with reduced toxicity.
Novel synthetic route for HCV NS5A inhibitor intermediate offering cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Patent CN103554117B enables high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing with metal-free catalysis.
Novel synthesis route for diazabicyclo derivatives offering enhanced structural diversity for pharmaceutical intermediate manufacturing and supply chain reliability globally.
Patent CN103396426B reveals novel NHC-Cu catalysis for chiral boronic acids. Enhances purity and reduces manufacturing costs for reliable pharmaceutical intermediate supply chains.
Patent CN103304478A details a high-yield Pictet-Spengler route for bis-tetrahydroisoquinoline alkaloids, offering cost-effective API intermediate manufacturing solutions.
This novel four-step synthetic route for Sitagliptin significantly reduces production costs and enhances optical purity for reliable API intermediate supply chains globally.
Discover advanced Cinchona-derived thiourea catalysts enabling high stereoselectivity. Reliable supplier for cost-effective organocatalysis solutions.
Patent CN102659919A details a cost-effective bortezomib synthesis using (R)-tert-butylsulfinamide, offering high purity and scalable manufacturing for global supply chains.
Novel patent CN119552158A details efficient Orforglipron synthesis using tert-butyl ester protection, offering cost reduction and scalability for pharmaceutical manufacturing supply chains.
Patent CN113429323A details a metal-free organocatalytic route for high-ee sulfonyl styrenes, offering cost-effective scalability for pharmaceutical intermediates.
Advanced 4-step synthesis of Shikimic Acid from crotonaldehyde. Patent CN102633629B offers high purity >98% ee, reduced waste, and reliable supply chain solutions.
Patent CN108503573B details a high-purity Brivaracetam route eliminating chiral separation. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN103880859B details a robust route for Vitamin H intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity thieno-imidazole-diketone.
Novel 5-step synthesis of KRAS G12D inhibitor intermediate 1 from L-proline. Reduces cost and complexity compared to ozonolysis routes.
Patent CN115894503A details a streamlined 5-step synthesis of a key pyrrolizine intermediate from L-proline, offering significant cost reduction and safer processing for API manufacturing.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Novel chiral preparation of Cinacalcet HCl via Patent CN101993379B. Eliminates toxic reductants, ensures high optical purity, and offers scalable API intermediate manufacturing solutions.